Walleye Trading’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-246
Closed -$102K 4834
2023
Q1
$115K Buy
+246
New +$130K ﹤0.01% 3788
2022
Q2
Sell
-1,036
Closed -$311K 5296
2022
Q1
$311K Buy
1,036
+577
+126% +$201K ﹤0.01% 3413
2021
Q4
$162K Sell
459
-3,193
-87% -$994K ﹤0.01% 4061
2021
Q3
$933K Buy
3,652
+1,451
+66% +$514K ﹤0.01% 2276
2021
Q2
$1.47M Buy
+2,201
New +$1.27M 0.01% 1783
2020
Q4
Sell
-749
Closed -$787K 4686
2020
Q3
$769K Sell
749
-91
-11% -$97.9K ﹤0.01% 1863
2020
Q2
$851K Sell
840
-305
-27% -$283K 0.01% 1809
2020
Q1
$995K Buy
+1,145
New +$1.14M 0.01% 1310
2019
Q4
Sell
-121
Closed -$124K 4362
2019
Q3
$112K Buy
+121
New +$133K ﹤0.01% 3286
2018
Q3
Sell
-62
Closed -$95.5K 5358
2018
Q2
$97K Sell
62
-325
-84% -$424K ﹤0.01% 4057
2018
Q1
$447K Buy
+387
New +$510K ﹤0.01% 2776
2017
Q1
Sell
-720
Closed -$385K 4819
2016
Q4
$385K Buy
+720
New +$360K ﹤0.01% 2298
2016
Q3
Sell
-20
Closed -$8K 5011
2016
Q2
$8K Buy
+20
New +$9.16K ﹤0.01% 4888

Other funds holding KYNB

Walleye Trading's KYNB Position: Q2 2023 in Review

Walleye Trading sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 246 shares — an estimated $102K sold.

Walleye Trading first reported a position in KYNB in Q2 2016 and held it in 13 quarters. The position peaked at $1.47M in Q2 2021. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Walleye Trading reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 246 Kyntra Bio shares in Q2 2023, an estimated $102K.
  • Walleye Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 13 quarters.
  • Walleye Trading's Kyntra Bio position peaked at $1.47M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.